Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 4/2015

01.12.2015 | short review

Thermoablation: a new treatment option to replace surgical intervention?

verfasst von: MD Dr. Herbert Schuster, Dr. Helmut Kopf

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten
share
TEILEN

Abstract

Local tumor ablation either by high or low temperatures is an ever increasing local therapeutic procedure in the interdisciplinary armamentarium of anticancer therapy. As cryoablation (local cancer tissue destruction by low temperature) is technically demanding, rather expansive and thus has gained low acceptance and low distribution in interventional oncologic radiology, this paper will focus on the state-of-the-art of local tumor cell destruction by high temperatures and electroporation: radiofrequency ablation (RFA), microwave ablation (MWA), and irreversible electroporation (IRE).
Literatur
2.
Zurück zum Zitat Bruix J, Sherman M, Llovet JM, et al.; EASL panel of experts on HCC. Clinical management of study of the liver. J Hepatol. 2001;35:421–30. Bruix J, Sherman M, Llovet JM, et al.; EASL panel of experts on HCC. Clinical management of study of the liver. J Hepatol. 2001;35:421–30.
3.
4.
Zurück zum Zitat Lencioni R, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228(1):235–40 PubMedCrossRef Lencioni R, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228(1):235–40 PubMedCrossRef
5.
Zurück zum Zitat Llovet JM, Vilana R, Bru C, et al.; Barcelona Clinic Liver Cancer (BCLC) Group. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;33:1124–9. Llovet JM, Vilana R, Bru C, et al.; Barcelona Clinic Liver Cancer (BCLC) Group. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;33:1124–9.
6.
Zurück zum Zitat Ruers T, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23(10):2619–26. PubMedPubMedCentralCrossRef Ruers T, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23(10):2619–26. PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Ruers T, et al. Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): long-term survival results of a randomized phase II study of the EORTC-NCRI CCSG- ALM Intergroup 40004 (CLOCC). J Clin Oncol. 2015; 33. (suppl; abstr 3501; oral presentation) Ruers T, et al. Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): long-term survival results of a randomized phase II study of the EORTC-NCRI CCSG- ALM Intergroup 40004 (CLOCC). J Clin Oncol. 2015; 33. (suppl; abstr 3501; oral presentation)
9.
Zurück zum Zitat Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243(3):321–8. PubMedPubMedCentralCrossRef Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243(3):321–8. PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Lu MD, Kuang M, Liang LJ, Xie XY, Peng BG, et al. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi. 2006;86(12):801–5. PubMed Lu MD, Kuang M, Liang LJ, Xie XY, Peng BG, et al. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi. 2006;86(12):801–5. PubMed
11.
Zurück zum Zitat Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242(2):158–71. PubMedPubMedCentralCrossRef Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242(2):158–71. PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Silen W. Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg. 1989;124(9):1021–2. PubMedCrossRef Silen W. Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg. 1989;124(9):1021–2. PubMedCrossRef
13.
Zurück zum Zitat Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection. The “Test-of-Time” approach. Cancer. 2003;97(12):3027–35. PubMedCrossRef Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection. The “Test-of-Time” approach. Cancer. 2003;97(12):3027–35. PubMedCrossRef
15.
Zurück zum Zitat Abi-Jaoudeh N, Kruecker J, Kadoury S, et al. Multimodality image fusion-guided procedures: technique, accuracy and applications. Cardiovasc Intervent Radiol. 2012;35:986–98. PubMedPubMedCentralCrossRef Abi-Jaoudeh N, Kruecker J, Kadoury S, et al. Multimodality image fusion-guided procedures: technique, accuracy and applications. Cardiovasc Intervent Radiol. 2012;35:986–98. PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Wood BJ, Kruecker J, Abi-Jaoudeh N, et al. Navigation systems for ablation. J Vasc Interv Radiol. 2010;21:257–63. CrossRef Wood BJ, Kruecker J, Abi-Jaoudeh N, et al. Navigation systems for ablation. J Vasc Interv Radiol. 2010;21:257–63. CrossRef
17.
Zurück zum Zitat Wallach D, Toporek G, Weber S, Bale R, Widmann G. Comparison of freehand-navigated and aiming device-navigated targeting of liver lesions. Int J Med Robot. 2014;10(1):35–43. PubMedCrossRef Wallach D, Toporek G, Weber S, Bale R, Widmann G. Comparison of freehand-navigated and aiming device-navigated targeting of liver lesions. Int J Med Robot. 2014;10(1):35–43. PubMedCrossRef
18.
Zurück zum Zitat Peng ZW, Zhang YJ, Chen MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol. 2013;31:426–32. PubMedCrossRef Peng ZW, Zhang YJ, Chen MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol. 2013;31:426–32. PubMedCrossRef
19.
Zurück zum Zitat Strickland AD, Clegg PJ, Cronin NJ, et al. Experimental study of large-volume microwave ablation in the liver. Br J Surg. 2002;89(8):1003–7. PubMedCrossRef Strickland AD, Clegg PJ, Cronin NJ, et al. Experimental study of large-volume microwave ablation in the liver. Br J Surg. 2002;89(8):1003–7. PubMedCrossRef
20.
Zurück zum Zitat Yang D, Converse MC, Mahvi DM, Webster JG. Measurement and analysis of tissue temperature during microwave liver ablation. IEEE Trans Biomed Eng. 2007;54(1):150–5. PubMedCrossRef Yang D, Converse MC, Mahvi DM, Webster JG. Measurement and analysis of tissue temperature during microwave liver ablation. IEEE Trans Biomed Eng. 2007;54(1):150–5. PubMedCrossRef
21.
Zurück zum Zitat Wang Y, Sun Y, Feng L, Gao Y, Ni X, Liang P. Internally cooled antenna for microwave ablation: results in ex vivo and in vivo porcine livers. Eur J Radiol. 2008;67(2):357–61. PubMedCrossRef Wang Y, Sun Y, Feng L, Gao Y, Ni X, Liang P. Internally cooled antenna for microwave ablation: results in ex vivo and in vivo porcine livers. Eur J Radiol. 2008;67(2):357–61. PubMedCrossRef
22.
Zurück zum Zitat Van Sonnenberg E, McMullen W, Solbiati L. Tumor ablation. Principles and practice. New York: Springer; 2005. CrossRef Van Sonnenberg E, McMullen W, Solbiati L. Tumor ablation. Principles and practice. New York: Springer; 2005. CrossRef
23.
Zurück zum Zitat Davalos R, Mir LM, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33(2):223–31. PubMedCrossRef Davalos R, Mir LM, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33(2):223–31. PubMedCrossRef
24.
Zurück zum Zitat Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat. 2007;6(307):307–12. PubMedCrossRef Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat. 2007;6(307):307–12. PubMedCrossRef
25.
Zurück zum Zitat Narayanan G, Bhatia S, Echenique A, Suthar R, Barbery K, Yrizarry J. Vessel patency post irreversible electroporation. Cardiovasc Intervent Radiol. 2014;37(6):1523–9. PubMedCrossRef Narayanan G, Bhatia S, Echenique A, Suthar R, Barbery K, Yrizarry J. Vessel patency post irreversible electroporation. Cardiovasc Intervent Radiol. 2014;37(6):1523–9. PubMedCrossRef
27.
Zurück zum Zitat Lencioni R, Crocetti L, Cioni D et al (2004) Percutaneous radiofrequency ablation of hepatic colorectal metastases. Technique, indications, results, and new promises. Invest Radiol 39:689–697 Lencioni R, Crocetti L, Cioni D et al (2004) Percutaneous radiofrequency ablation of hepatic colorectal metastases. Technique, indications, results, and new promises. Invest Radiol 39:689–697
28.
Zurück zum Zitat Gillams AR, Lees WR (2004) Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 14:2261–2267 Gillams AR, Lees WR (2004) Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 14:2261–2267
29.
Zurück zum Zitat Machi J, Oishi AJ, Sumida K et al (2006) Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management. Cancer J 12:318–326 Machi J, Oishi AJ, Sumida K et al (2006) Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management. Cancer J 12:318–326
30.
Zurück zum Zitat Sorensen SM, Mortensen FV, Nielsen DT (2007) Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 48:253–258 Sorensen SM, Mortensen FV, Nielsen DT (2007) Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 48:253–258
31.
Zurück zum Zitat Veltri A, Sacchetto P, Tosetti I, Pagano E, Fava C, Gandini G (2008) Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 31:948–956 Veltri A, Sacchetto P, Tosetti I, Pagano E, Fava C, Gandini G (2008) Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 31:948–956
Metadaten
Titel
Thermoablation: a new treatment option to replace surgical intervention?
verfasst von
MD Dr. Herbert Schuster
Dr. Helmut Kopf
Publikationsdatum
01.12.2015
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 4/2015
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-015-0232-6